Publications | CDI Pathogenesis and Therapy - Wang Lab at Biomedical Sciences of HCOM

2018

Wang, Shaohua. 2018. “Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-Human Primate, and Human Feces. Front Microbiol 9: 2897.”

Wang, Shaohua. 2018. “Genome Engineering of Clostridium Difficile Using the CRISPR-Cas9 System.”

Wang, Shaohua. 2018. “Obesity-Linked Gut Microbiome Dysbiosis Associated With Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet.”

Wang, Shaohua. 2018. “Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-Human Primate, and Human Feces.”

Wang, Shaohua. 2018. “Human-Origin Probiotic Cocktail Increases Short-Chain Fatty Acid Production via Modulation of Mice and Human Gut Microbiome.”

Wang, Shaohua. 2018. “Gut Microbiome and Aging: Physiological and Mechanistic Insights.”

2017

Wang, Shaohua. 2017. “Enhancement of Solvent Production by Overexpressing Key Genes of the Acetone-Butanol-Ethanol Fermentation Pathway in Clostridium Saccharoperbutylacetonicum N1-4.”

Wang, Shaohua. 2017. “Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.”

Wang, Shaohua. 2017. “Genome Editing in Clostridium Saccharoperbutylacetonicum N1-4 With the CRISPR-Cas9 System.”

2016

Wang, Shaohua. 2016. Genetically engineered bacterium for producing natamycin as well as construction method and application of genetically engineered bacterium, issued 2016.